C-TYROCapacity Bio
mitophagy, mitochondrial modulators, small molecules
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
C-TYROmitophagy, mitochondrial modulators, small molecules
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Capacity Bio presents itself as "The Mitophagy Company," indicating a belief that mitophagy is a core biological process worth targeting, and states that focusing on fundamental biology can produce radical therapeutic benefits.
SourceCapacity Bio states that mitophagy is a fundamental, evolutionarily conserved cellular quality-control process that maintains healthy mitochondrial mass by identifying, removing, and replacing dysfunctional mitochondria. The company argues that in aging and disease this process becomes deficient, causing damaged mitochondria to accumulate and drive reactive oxygen species release, inflammatory signaling, calcium dysregulation, reduced ATP production, and cell death. Its stated belief is that safely enhancing mitophagy can counter these defects and enable therapeutic breakthroughs.
SourceCapacity Bio presents itself as "The Mitophagy Company," indicating a belief that mitophagy is a fundamental biological process worth targeting in order to achieve radical therapeutic benefits.
Source